A pH-responsive polymer gel could create swallowable devices, including capsules for ultra-long drug delivery
Medical devices designed to reside in the stomach have a variety of applications, including prolonged drug delivery, electronic monitoring, and weight-loss intervention. However, these devices, often created with nondegradable elastic polymers, bear an inherent risk of intestinal obstruction as a result of accidental fracture or migration. As such, they are usually designed to remain in the stomach for a limited time.
Now, researchers at MIT’s Koch Institute for Integrative Cancer Research and Massachusetts General Hospital (MGH) have created a polymer gel that overcomes this safety concern and could allow for the development of long-acting devices that reside in the stomach, including orally delivered capsules that can release drugs over a number of days, weeks, or potentially months following a single administration.
This polymer is pH-responsive: It is stable in the acidic stomach environment but dissolves in the small intestine’s near-neutral pH, allowing for safe passage through the remainder of the gastrointestinal (GI) tract. The material is also elastic, allowing for the compression and folding of devices into easily ingestible capsules — meaning this polymer can be used to create safe devices designed for extremely prolonged residence in the stomach.
“One of the issues with any device in the GI tract is that there’s the potential for an obstruction, which is a medical emergency potentially requiring surgical intervention,” says Koch Institute research affiliate Giovanni Traverso, also a gastroenterologist at MGH and an instructor at Harvard Medical School. “A material like this represents a real advance because it is both safe and stable in the stomach environment.”
Traverso and Robert Langer, the David H. Koch Institute Professor at MIT and a member of the Koch Institute, are the senior authors of a paper in the July 27 issue of Nature Materials that describes the application of this new polymer gel for creating gastric devices. Shiyi Zhang, a postdoc at the Koch Institute, is the paper’s lead author.
Designing devices for the stomach is a complicated matter of sizes and shapes. The stomach naturally empties its contents in a matter of hours, so for devices to be retained, they must be wider than the pylorus — the valve at the end of the stomach, about 1.5 to 2 centimeters in diameter, that allows gastric contents to pass into the small intestine. However, because the most convenient path to deliver these devices is through the esophagus, which is only marginally wider than the pylorus, the researchers were interested in developing a polymer with elastic properties.
“An elastic device can be folded into something small, such as a capsule, and be easily ingested through the esophagus before expanding in the stomach, restoring its original shape,” Zhang says. “When you have a device that’s larger than the pylorus, there’s a much higher probability that it will be retained longer in the stomach.”
But the size and shape of existing devices with elastic polymers have been limited by safety concerns, as there is a greater risk for fracture if a device is too large or too complex. Because of this, the researchers wanted their polymer to also be enteric — or have a mechanism that would enable it to pass through the stomach unaltered before disintegrating in the intestines.
“To lower any possible risk of obstruction, we wanted a material that could dissolve in the intestines, thereby dissociating the device, and safely pass out of the body,” Zhang says.
To create this new material, the researchers synthesized an elastic polymer and combined it in solution with a clinically utilized enteric polymer. Adding hydrochloric acid and centrifuging the solution resulted in a flexible, yet resilient, polymer gel that exhibits both elastic and enteric properties.
The researchers used the gel polycaprolactone (PCL), a nontoxic, degradable polyester, to construct several device prototypes. They first created ring-shaped devices by using the gel to link arcs of PCL in a circular mold. These elastic devices had a diameter of 3 centimeters — wider than the pylorus — before they were folded into orally ingestible capsules.
In testing the capsules in pigs, the researchers found that the rings expanded into their original shape within 15 minutes of ingestion and remained in the stomach for up to seven days. After the device passed out of the stomach, the polymer gel dissolved, allowing for the safe passage of the small PCL pieces without obstruction. The researchers also created larger devices in various shapes that could be folded and delivered through the esophagus with the assistance of an endoscope. These devices remained in the stomach for up to five days, after which the gel similarly dissolved, allowing for the remnants of the device to safely pass.
Read more: New material opens possibilities for super-long-acting pills
The Latest on: Long-acting pills
[google_news title=”” keyword=”long-acting pills” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Long-acting pills
- Weight-loss drugs may also curb addictionson June 1, 2023 at 1:55 pm
Ferguson is one of many patients taking drugs for weight loss who say they also lost interest in some addictive behaviors. Doctors told CNN that patients most commonly report an effect on alcohol use.
- Want long-term contraception? There are more effective options than the pill—but they can be hard to findon June 1, 2023 at 7:52 am
Australians' access to a range of contraceptive options depends on where they live and how wealthy they are. A recent parliamentary inquiry recommends ways to end this "postcode lottery" for people ...
- Safe, Effective Male Contraceptive Pill - The Long Wait News, Research and Latest Updateson May 30, 2023 at 5:00 pm
Keep abreast with the latest news related to Safe, Effective Male Contraceptive Pill - The Long Wait there are 289 news items on Safe, Effective Male Contraceptive Pill - The Long Wait that covers ...
- Mounjaro vs. Ozempic: The side effects of the two weight-loss drugs explained by a doctoron May 30, 2023 at 6:50 am
Users of weight-loss drugs like Ozempic and Wegovy often experience common side effects like nausea and diarrhea. Competitor Mounjaro may cause similar but milder symptoms.
- EyePoint Pharmaceuticals: A Puncher's Chance For Long Acting Eye Disease Drug Successon May 30, 2023 at 5:00 am
EyePoint Pharmaceuticals is a $200m market cap biotech focused on eye disease. Read more to see a full investment analysis of EYPT stock.
- Viagra vs. Cialis and Levitra vs. Stendra: Which Is Best in 2023?on May 25, 2023 at 5:00 pm
how long they work, and what their side effects are. Viagra, Cialis, Levitra, and Stendra are all in a class of medications called phosphodiesterase type 5 (PDE5) inhibitors. These drugs work by ...
- Public hospital abortions and cheaper contraceptives needed, inquiry findson May 25, 2023 at 2:01 pm
The Greens-led inquiry also recommended cheaper access to contraceptive pills and long-acting birth control amid concern it costs women hundreds of dollars they cannot always afford. Greens ...
- Concerta vs. Ritalin: Dosage Differences & Moreon May 18, 2023 at 5:00 pm
The greatest consideration in deciding between the two drugs may be whether a long-acting or short-acting version is best. This choice depends on the severity, frequency, and timing of your symptoms.
- 12 Best Returns To Acting After a Long Hiatuson May 18, 2023 at 7:55 am
After taking the red pill, Keanu left because he was just tired ... Robert Downey Jr. RDJ took an unplanned four-year break from acting to deal with his well-documented addiction and legal issues.
- Ronkonkoma man who sold fentanyl pills that looked like oxycodone injured police while fleeing, Suffolk DA sayson May 10, 2023 at 10:00 pm
A Ronkonkoma man was arraigned Wednesday on charges that he sold fentanyl pills and ran over a police ... and one count of resisting arrest. Acting Supreme Court Justice Richard I.
via Bing News